Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
about
Progress in vaccination towards hepatitis B control and elimination in the Region of the AmericasHepatitis B virus: where do we stand and what is the next step for eradication?Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in ColombiaHepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis StudyAssociation of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants.Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey.Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals.Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.Hepatitis B virus burden in developing countries.Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.Epidemiological, serological and molecular aspects of hepatitis B and C in children and teenagers of municipal daycare facilities schools and schools in the city of Santos.Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, ColombiaLevels of regulatory B cells do not predict serological responses to hepatitis B vaccine.Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh
P2860
Q33568248-3D7F7FBC-F2A2-4650-8F56-D0EAFC58F51CQ33958764-77344958-8DCD-4F88-B183-988AEC0E7F97Q35224439-BA408E2D-15ED-4D12-9C2E-0F6BD643BF0FQ35512329-7DFDA34E-A687-466D-93FA-27AAC19A32E5Q35671639-DDE78AEA-9DEB-43AB-B95D-16F7D534A94FQ35814057-8AFAFABE-899A-4375-9AEE-53DE790FD71CQ35877899-0E2D9736-90E8-493A-971C-01C8EDA71FC4Q36083447-8039DE0C-206B-4128-A5C8-4FD3423F91C5Q36122062-AD6EA40B-6F35-4742-B29F-836B853BA321Q36203353-4255354B-D27C-4DC4-B310-7BFA5CA7BDDEQ36269649-D0D40B21-B920-4D1D-B2B5-7C74DA846B42Q36450875-0AAF7D96-060C-4802-8176-D8B55AF3DE0CQ38919435-CB5E9095-3052-438E-A58F-8CF8E8972ECDQ40225766-1B830EF2-6E5B-454B-8CAD-8421B6C75F01Q41920891-92F080CD-C35D-4C8D-B7FD-5B7FB42168D5Q52730804-525E6AFB-B984-45DD-BFDA-44D25D6549B8Q57922923-E22DF24C-6279-4B42-869F-01A7E043768C
P2860
Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Eight years of hepatitis B vac ...... s infection and effectiveness.
@en
Eight years of hepatitis B vac ...... s infection and effectiveness.
@nl
type
label
Eight years of hepatitis B vac ...... s infection and effectiveness.
@en
Eight years of hepatitis B vac ...... s infection and effectiveness.
@nl
prefLabel
Eight years of hepatitis B vac ...... s infection and effectiveness.
@en
Eight years of hepatitis B vac ...... s infection and effectiveness.
@nl
P2093
P1476
Eight years of hepatitis B vac ...... s infection and effectiveness.
@en
P2093
Andrew J Hall
Fernando de la Hoz
Ligia Perez
Marlen de Neira
P304
P356
10.1016/J.IJID.2007.06.010
P577
2007-10-02T00:00:00Z